Infosys gains nearly 1% on signing deal with Prime Therapeutics

Subscribe to GoodReturns

Infosys gains nearly 1% on signing deal with Prime Therapeutics
Shares of Infosys rose nearly 1 per cent in early trade on Bombay Stock Exchange (BSE) after it said that it signed a three-year contract with Prime Therapeutics to set up a testing centre of excellence (COE) and consolidate the delivery of its application testing services

The shares of company rose as much as 0.92 per cent to trade at Rs 3258.35 a piece on the BSE.

In a similar fashion, shares of the company rose 0.93 per cent to Rs 3261 a piece on National Stock Exchange.

Meanwhile, the broader benchmark Sensex was quoting at 22,253.12, up 38.75 points or 0.17 per cent at 10:42 hours.

Dion Global Solutions Ltd.

Story first published: Friday, March 28, 2014, 13:07 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?